Towa Pharmaceutical Co Ltd 2022 Integrated Report
Company: Towa Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Integrated Report
Pages: 54
The report presents Towa Group's value creation story under its 2021–2023 PROACTIVE II plan, emphasizing generics, overseas growth, health-related businesses, technology innovation and human resources. FY2021 consolidated net sales reached JPY 165,615 million, while the report records 39,415 t-CO2 emissions, 278,060 m3 of water usage, 20,203 kl of energy usage and 2,221 t of waste. It also describes the new Environment, Health and Safety Management Department and TCFD-related scenario analysis, alongside the acquisition of Sunsho Pharmaceutical.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.